The goal of this program is to improve the diagnosis and management of hematologic or solid tumor malignancies. After hearing and assimilating this program, the clinician will be better able to: 1. Administer imetelstat to patients with lower-risk myelodysplastic syndrome when indicated. 2. Explain the mechanism of action of exagamglogene autotemcel. 3. Optimize use of axatilimab in patients with chronic graft vs host disease.
- Provider:Lippincott Continuing Medical Education Institute, Inc.
- Activity Link: https://www.audio-digest.org/Specialties/Oncology
- Start Date: 2024-12-04 06:00:00
- End Date: 2024-12-04 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.75 hours
- MOC Credit Details: ABIM - 1.75 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Yes
- Measured Outcome: Learner Competence, Learner Knowledge, Learner Performance
- Provider Ship: Jointly Provided
- Registration: Open to all
- Specialty: Medical Oncology
Subscribe
Login
0 Comments
Oldest